Finance

Roʻyxatlar
A58:ETR
Elevance Health
381,00 €
+0,79%
(+3,00) 1K
14-okt, 13:17:56 (GMT+2)  ·   EUR
Barcha belgilar
BelgiNarxiOʻzgartirishlarDinamika (%)
A58 tikeri uchun statistika yaratilmoqda...
Ochish
379,60 €
Yuqori
381,00 €
Past
379,60 €
Bozor kapitali
92,23 mlrd
Oʻrtacha hajm
11,00
Hajmi
0,00
52 haftalik eng yuqori
381,00 €
52 haftalik eng past
241,60 €
Xodimlar soni
97 ming
Ochish
379,60 €
Yuqori
381,00 €
Past
379,60 €
Bozor kapitali
92,23 mlrd
Oʻrtacha hajm
11,00
Hajmi
0,00
52 haftalik eng yuqori
381,00 €
52 haftalik eng past
241,60 €
Xodimlar soni
97 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans. Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing /Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States. Wikipedia
Elevance Health haqida
CEOGail Koziara Boudreaux
Xodimlar soni96,6 ming
Asos solingan1944
Bosh ofislarIndianapolis, Indiana, Amerika Qo‘shma Shtatlari
SektorHealth care provider
Avvalgi hisobotlarBarcha qiymatlar – USD
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar – USD
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
50,71 mlrd
49,75 mlrd
50,18 mlrd
50,47 mlrd
Sotilgan mahsulotning tannarxi
38,14 mlrd
38,06 mlrd
35,62 mlrd
37,02 mlrd
Daromad narxi
38,14 mlrd
38,06 mlrd
35,62 mlrd
37,02 mlrd
Tadqiqot va ishlanmalarga xarajatlar
-
-
-
-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maʼmuriy xarajatlar
10,65 mlrd
10,75 mlrd
11,79 mlrd
11,04 mlrd
Operatsion xarajatlar
10,81 mlrd
10,92 mlrd
11,90 mlrd
11,15 mlrd
Jami operatsion xarajatlar
48,95 mlrd
48,98 mlrd
47,52 mlrd
48,17 mlrd
Operatsion daromad
1,76 mlrd
766,00 mln
2,66 mlrd
2,30 mlrd
Boshqa nooperatsion daromad
-
-
-
-
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar
1,41 mlrd
215,00 mln
2,30 mlrd
1,94 mlrd
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno
1,41 mlrd
399,00 mln
2,30 mlrd
1,94 mlrd
Daromad soligʻi boʻyicha xarajat
219,00 mln
-331,00 mln
544,00 mln
483,00 mln
Amaldagi soliq stavkasi
15,58%
-153,95%
23,61%
24,94%
Boshqa operatsion xarajatlar
-
-
-
-
Sof foyda
1,19 mlrd
547,00 mln
1,76 mlrd
1,46 mlrd
Sof foyda marjasi
2,34%
1,10%
3,52%
2,90%
Har bir aksiya foydasi
6,03
3,33
12,58
7,45
Foizlar va investitsiyalardan olingan daromadlar
-
-
-
-
Foizlarni toʻlash xarajatlari
-351,00 mln
-367,00 mln
-357,00 mln
-364,00 mln
Foizlarni toʻlash boʻyicha sof xarajatlar
-351,00 mln
-367,00 mln
-357,00 mln
-364,00 mln
Amortizatsiya ajratmalari
-
-
-
-
EBITDA
2,14 mlrd
1,17 mlrd
3,02 mlrd
2,67 mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boʻlishi mumkin. Batafsil
Google ilovalari